Implantable glucose sensor company Senseonics has launched a remote monitoring app for its users in Europe, the Middle East, and Africa, where its CGM system is distributed by Roche. The app, called Eversense Now, allows users of the sensor to select up to five friends or family members to view their glucose data, which is updated every five minutes. The feature is available for iOS users at the moment, with plans for Android in the works.
from MobiHealthNews http://ift.tt/2og3IZm
February 22, 2018
Rose
MobiHealthNews
No comments
Related Posts:
Precision Health AI launches new platform to synthesize oncology dataArtificial intelligence has been working its way into the field of research. Now Precision Health AI, a company that specializes in applications of AI to oncology, has just launched a new platform, called Eureka Health O… Read More
athenahealth reveals mobile app Epocrates Connect for EHR coordinationathenahealth will be debuting Epocrates Connect, a mobile app that directly connects into a provider’s EHR system, at HIMSS 2018 next week. The system uses machine learning and language processing to give providers access to … Read More
Helix raises $200 million to grow genomics testing marketplaceHelix has closed a $200 million financing round and said it plans to expand its personal genomics marketplace to accelerate consumer adoption of genomics. from MobiHealthNews http://ift.tt/2t9Iwce … Read More
PlushCare taps Thermo Fisher Scientific to offer telemedicine allergy consultationsPlushCare, a direct-to-consumer telemedicine service that originally focused on acute and urgent care, has partnered with Thermo Fisher Scientific to add allergy testing to its offerings. PlushCare users will have access to T… Read More
In-Depth: Defining the burgeoning field of digital therapeutics From syringes to workflow management systems, healthcare is no stranger to adopting new technologies into standard care. As digital and connected technologies continue to stake their claim in the industry, the last few … Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment